← Every applicant
Inforlife FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDENew drugApr 17, 2024INJECTABLE, INTRAVENOUS |
| ACETAMINOPHENNew drugMay 3, 2023SOLUTION, INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENew drugSep 15, 2022SOLUTION, INTRAVENOUS |
| MIDAZOLAM IN 0.9% SODIUM CHLORIDENew drugMar 22, 2021SOLUTION, INTRAVENOUS |